Krista Evans Email & Phone Number
@astrazeneca.com
3 phones found area 301
LinkedIn matched
Who is Krista Evans? Overview
A concise factual answer block for searchers comparing this professional profile.
Krista Evans is listed as Retired at Retired from AstraZeneca, based in Germantown, Maryland, United States. AeroLeads shows a work email signal at astrazeneca.com, phone signal with area code 301, and a matched LinkedIn profile for Krista Evans.
Krista Evans previously worked as Associate Director at Astrazeneca and Scientist I at Medimmune. Krista Evans holds B.S., Biology from Shepherd University.
Email format at Retired from AstraZeneca
This section adds company-level context without repeating Krista Evans's masked contact details.
AeroLeads found 1 current-domain work email signal for Krista Evans. Compare company email patterns before reaching out.
About Krista Evans
Associate Director currently working with CMC regulatory submissions and adventitious biosafety testing of cell banks, virus seeds, and unprocessed bulks. I work to maintain compliance of biosafety testing with global regulatory guidance. Expert in TSE-BSE risk assessment of raw materials and cell lines.I have experience in technology development, drug discovery screening, product development, regulatory writing, and setting quality control standards for product manufacture. My areas of expertise include mammalian cell culture, cell-based assays, transfections/ electroporations, gene expression, generation of stable cell lines, fluorescence microscopy, high throughput screening, assay development, adventitious safety testing, and regulatory CMC submissions.
Listed skills include Cell Culture, Assay Development, Cell, High Throughput Screening, and 35 others.
Krista Evans's current company
Company context helps verify the profile and gives searchers a useful next step.
Krista Evans work experience
A career timeline built from the work history available for this profile.
Role listed
Associate Director
Perform authoring/verifying/reviewing upstream sections of CMC regulatory submissions for clinical trial and marketing applications. Act as SME for responses to Health Authorities questions involving animal-derived materials and adventitious agent safety testing and characterization of production cell banks, virus seeds, and unprocessed bulks. Responsible for authoring TSE-BSE risk assessments for cell banks and animal-derived raw materials used in upstream activities. Support in-licensed projects by reviewing documentation for compliance and perform gap assessments. Provide lifecycle management technical guidance and support for post-approval cell culture and raw material investigations and regulatory submissions. Retirement date is 15Dec2023.
Scientist I
Currently involved in scientific and regulatory writing of development reports, INDs, and BLAs as well as risk assessments for and safety testing of cell banks. Developed protocols for Cell Therapy team for use in CAR-T projects. Created protocols for CHO cell cloning and single cell verification of clonality using 384-well plates, FACS, and plate imaging. Investigated cell product aggregation for difficult-to-express proteins. Developed transfection and selection protocols for FUT-8 knockout cell line and other CHO cell lines. Lead media development efforts for low-density cell growth of CHO cells. Developed protocols for freezing and thawing CHO cells in a 96-well plate format.
Associate Scientist Ii
Team lead for CHO cell cloning and single cell verification of clonality using 384-well plates, FACS, and plate imaging project. Lead media development efforts for low-density cell growth of a variety of CHO-derived cells. Lead technology development efforts in optimizing protocols for a FUT-8 knockout cell line development process. Developed protocols for freezing and thawing CHO cells in a 96-well plate format. Provided support in transfection, selection, and cloning to Cell Line Development team.
Associate Scientist Ii
Member of Cell Line Engineering Group in R&D. Generated stable mammalian cell lines for production of biopharmaceuticals by transfection and electroporation. Optimized protocols for cell line generation in multiple host lines using the GS system. Created high-titer, stable cell lines in CHO and NS0 lines for production. Evaluated stability of clones using intracellular staining and flow cytometry.
Sr. Associate Scientist
Member of Lead Discovery Target Team. Responsible for RNAi transfections, analysis, and small molecule RNAi-mimic-based screen using microarray and qPCR. Focal member of RNAi Team as part of Avalon’s target discovery efforts. Developed assays for evaluating RNAi transfection/electroporation efficiency and monitoring non-specific effects. Assisted in creating a beta catenin intangible-target screen using genes affected by RNAi silencing of beta catenin in colon cancer cells.Developed and evaluated proliferation assays as part of secondary screening platform. Developed BrdU, ATP, mitochondrial potential, live/dead, tubulin polymerization, soft agar, and cell adhesion assays in-house. Assisted in data mining efforts using software from Gene Logic and Compugen. Assisted in microarray data analysis. Performed 3D cell culture experiments using various methods including the rotary cell culture system from Synthecon (RCCS).
Scientist
Member of the cationic lipid transfection team in R&D Gene Expression Group producing pGreenLantern, LipofectAMINE PLUS, LipofectAMINE 2000, OligofectAMINE. Responsible for quality control development and stability studies for state of the art products.Instrumental in product development and release of successful new transfection products. Wrote product quality control documents and spreadsheets for use in manufacturing. Assisted in training and transfer of QC from R&D to manufacturing.Developed fluorescent and luminescent assays to monitor gene expression. Developed automated data analysis worksheets using Excel macros.
Krista Evans education
B.S., Biology
A.A., Accounting And Business
Frequently asked questions about Krista Evans
Quick answers generated from the profile data available on this page.
What company does Krista Evans work for?
Krista Evans works for Retired from AstraZeneca.
What is Krista Evans's role at Retired from AstraZeneca?
Krista Evans is listed as Retired at Retired from AstraZeneca.
What is Krista Evans's email address?
AeroLeads has found 1 work email signal at @astrazeneca.com for Krista Evans at Retired from AstraZeneca.
What is Krista Evans's phone number?
AeroLeads has found 3 phone signal(s) with area code 301 for Krista Evans at Retired from AstraZeneca.
Where is Krista Evans based?
Krista Evans is based in Germantown, Maryland, United States while working with Retired from AstraZeneca.
What companies has Krista Evans worked for?
Krista Evans has worked for Retired From Astrazeneca, Astrazeneca, Medimmune, Avalon Pharmaceuticals, and Invitrogen.
How can I contact Krista Evans?
You can use AeroLeads to view verified contact signals for Krista Evans at Retired from AstraZeneca, including work email, phone, and LinkedIn data when available.
What schools did Krista Evans attend?
Krista Evans holds B.S., Biology from Shepherd University.
What skills is Krista Evans known for?
Krista Evans is listed with skills including Cell Culture, Assay Development, Cell, High Throughput Screening, Elisa, Mammalian Cell Culture, Monoclonal Antibodies, and Flow Cytometry.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial